Cover Feature: Tetrahydroindolone‐Dihydropyrimidinone Hybrids as Promising Antibiofilm and Antibacterial Agents (ChemMedChem 23/2025)

Novel tetrahydroindolone dihydropyrimidinone hybrid compounds exhibited significant antibiofilm activity against resistant bacterial Staphylococcus aureus and Pseudomonas aeruginosa strains, indicating molecular hybridization played crucial role to this performance. Toxicity studies using Caenorhabditis elegans model revealed no observable toxicity, even at elevated concentrations. Combination of strong antibiofilm activity with non-toxic behavior underlines the antivirulence potential, positioning the hybrid compounds as promising adjuvants in the fight against chronic bacterial infections. More details can be found in the Research Article by Karine R. Zimmer, Dennis Russowsky, and co-workers (DOI: 10.1002/cmdc.202500716).